Cairn Biosciences
Cairn Biosciences is a company dedicated to discovering new medicines by mapping multiscale cell dynamics. Their proprietary COMPASS discovery platform enables the exploration of complex disease biology to identify novel targets and drugs. The team is pioneering a new drug discovery paradigm using innovative simulations of living biology, initially focusing on overcoming acquired resistance to targeted cancer therapies.
Industries
Nr. of Employees
small (1-50)
Cairn Biosciences
Patents
Methods for dynamic evolution and monitoring of characteristics in living cells using a microfluidic-enabled multi-well cell culture devices and systems
US-12258551-B2
View DetailsMicrofluidic-enabled multiwell cell culture devices and systems for precision culture, control and monitoring of living cells
US-11946035-B2
View Details
Methods for dynamic evolution and monitoring of characteristics in living cells using a microfluidic-enabled multi-well cell culture devices and systems
US-12258551-B2
View DetailsMicrofluidic-enabled multiwell cell culture devices and systems for precision culture, control and monitoring of living cells
US-11946035-B2
View DetailsProducts
COMPASS discovery platform
A proprietary platform used for discovering new drugs by mapping multiscale cell dynamics, focusing on novel targets and drugs through the simulation of living biology.
Drug discovery for targeted cancer therapies
Focuses on discovering drugs that overcome acquired resistance to targeted cancer therapies, utilizing the COMPASS platform.
COMPASS discovery platform
A proprietary platform used for discovering new drugs by mapping multiscale cell dynamics, focusing on novel targets and drugs through the simulation of living biology.
Drug discovery for targeted cancer therapies
Focuses on discovering drugs that overcome acquired resistance to targeted cancer therapies, utilizing the COMPASS platform.
Services
In-house R&D platform that integrates experimental simulation of cellular systems, live-cell imaging, and computational analysis to identify therapeutic targets, biomarkers and candidate compounds.
In-house R&D platform that integrates experimental simulation of cellular systems, live-cell imaging, and computational analysis to identify therapeutic targets, biomarkers and candidate compounds.
Expertise Areas
- Simulation-based disease modeling
- Live-cell imaging and high-content screening
- Cell line engineering and gene editing
- Computational biology and biological simulation
Key Technologies
- Live-cell fluorescence microscopy
- High-content imaging
- Image analysis and processing pipelines
- Microscope automation scripting